Publications and thought leadership

  • Research
A journey with LGMD:
From protein abnormalities to patient impact
  • White Paper
Adaptive Transformation: 
US healthcare burden
  • White Paper
Adaptive Transformation: Pharma sales bend or break
  • White Paper
Adaptive Transformation: Telemedicine comes of age
  • White Paper
Adaptive Transformation: Voices from the front line
  • White Paper
COVID-19 patient journey: Progression, diagnosis and treatments in development
  • Research
Payers leverage off label Bevacizumab to control ophthalmology costs
  • Research
Keeping it fair in rare – what every pharma can learn from ultra-orphan sales incentive plan design
  • Research
$200,000 the new max? 
Payers start to redefine 
“proven and medically necessary”
  • Research
Claims data analytics. Now available for pipeline brands.
  • Research
Alignments from scratch in hours, not weeks, not months. Data included.
  • Research
You won president’s club. Again. Great! Now what?
  • Research
Ultra-orphan IC design

Recognition

Award-winning analytics

We utilize the latest advancement in analytics, science, and technology to serve a broad range of pharmaceutical, biotech, gene therapy and medical device companies with personalized services.

We were recognized with the “Best Partner” Award for Field Operations / Incentive Compensation in 2017, based entirely on client feedback.

We continuously push ourselves to broaden and deepen our expertise to honor and share the remarkable scientific breakthroughs unfolding every single day.

Transform with us

Contact us
  • New York 646.926.0208
  • Chicago 847.868.0208
  • San Francisco 415.347.9565
  • Boston 617.229.6063
  • Delhi +91-1244006616
  • New York 646.926.0208
  • Chicago 847.868.0208
  • San Francisco 415.347.9565
  • Boston 617.229.6063
  • Delhi +91-1244006616

NEW PROJECTS

info@qralgroup.com

JOIN THE TEAM

recruiting@qralgroup.com

Qral Group LLC © 2024